Join us!

The Cancer Dependency Map Project (DepMap), launched by the Broad Institute’s Cancer Program, aims to systematically identify the genetic and chemical vulnerabilities across human cancers. Using a host of new technologies like CRISPR-based gene editing, pooled drug screening, and next-generation sequencing, we have deeply characterized over a thousand different cancer models and produced some of the largest cancer datasets in the world, which are now being widely used to identify new vulnerabilities in this devastating disease.

DepMap is a collaborative effort involving teams from across the Broad Institute, including the Cancer Data Science and Target Discovery and Advancement teams. Whether you are a software engineer, bench biologist, or project manager by trade, there are many ways you can help us drive advances in precision oncology. See below for our current openings and how you can apply to join the Cancer Dependency Map team!